| 產(chǎn)品名稱 | KW 6002 - Istradefylline |
| 產(chǎn)品貨號 | Axon 1423 CAS [155270-99-8] MF C20H24N4O4MW 384.43 Purity: 99% Soluble in DMSO Description Very potent, selective and orally active adenosine A2A receptor antagonist in experimental models of Parkinson's disease References Certificates Categories Extra info S Shiozaki et al. Actions of adenosine A2A receptor antagonist KW-6002 on drug-induced catalepsy and hypokinesia caused by reserpine or MPTP. Psychopharmacology (Berl). 1999, 147(1), 90-95.? ? TN Chase et al. Translating A2A antagonist KW6002 from animal models to parkinsonian patients. Neurology 2003, 61(11 Suppl 6), S107-11.? ? PA LeWitt et al. Adenosine A2A receptor antagonist istradefylline (KW-6002) reduces "off" time in Parkinson's disease: a double-blind, randomized, multicenter clinical trial (6002-US-005). Ann. Neurol. 2008, 63(3), 295-302. Certificate of Analysis Material Safety Data Sheet Cardiovascular CNS A2A A18 Adenosine A2A antagonist Chemical name 8-[(E)-2-(3,4-Dimethoxy-phenyl)-vinyl]-1,3-diethyl-7-methyl-3,7-dihydro-purine-2,6-dione Parent CAS No. [155270-99-8] Order Size Unit Price Stock 5 mg €85.00 In Stock |
| 產(chǎn)品價格 | 現(xiàn)貨詢價，電話：010-67529703 |
| 產(chǎn)品規(guī)格 | |
| 產(chǎn)品品牌 | axonmedchem |
| 產(chǎn)品概述 | |
| 產(chǎn)品詳情 |
KW 6002 - IstradefyllineAxon 1423 CAS [155270-99-8] MF C20H24N4O4
Description
Very potent, selective and orally active adenosine A2A receptor antagonist in experimental models of Parkinson's disease
Adenosine A2A antagonist
Chemical name8-[(E)-2-(3,4-Dimethoxy-phenyl)-vinyl]-1,3-diethyl-7-methyl-3,7-dihydro-purine-2,6-dione Parent CAS No.[155270-99-8] |
| 產(chǎn)品資料 |
